Nanomedicine-Assisted Combination Therapy of NSCLC: New Platinum-Based Anticancer Drug Synergizes the Therapeutic Efficacy of Ganetespib

Nanotheranostics - Australia
doi 10.7150/ntno.28468
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ivyspring International Publisher

Related search

Glyconanoparticles for Targeted Tumor Therapy of Platinum Anticancer Drug

English

Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine

Current Drug Metabolism
Clinical BiochemistryPharmacology
2013English

Triapine Potentiates Platinum-Based Combination Therapy by Disruption of Homologous Recombination Repair

British Journal of Cancer
Cancer ResearchOncology
2016English

Augmentation of EPR Effect and Efficacy of Anticancer Nanomedicine by Carbon Monoxide Generating Agents

Pharmaceutics
Pharmaceutical Science
2019English

Microwave-Assisted Synthesis of New 1,3-Thiazolidin-4-Ones and Evaluation of Their Anticancer Efficacy

Modern Applied Science
2011English

Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors

Journal of Biomedicine and Biotechnology
2011English

Nanomedicine, an Emerging Therapeutic Strategy for Oral Cancer Therapy

Oral Oncology
Cancer ResearchOral SurgeryOncology
2018English

A New Platinum(II) Compound Anticancer Drug Candidate With Selective Cytotoxicity for Breast Cancer Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

New Insight of Antiretroviral Drug Efavirenz as Anticancer Agents for Breast Cancer Therapy

Cancer Cell & Microenvironment
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy